Acino
Nahla Zein has extensive experience in regulatory affairs, currently serving as the Regulatory Affairs Head and Scientific Office Manager at Acino since March 2021, where responsibilities include preparing regulatory strategies for Middle East and Africa countries and representing regulatory affairs on the Egypt & NDM leadership team. Prior experience includes roles at AbbVie as a Senior Regulatory Affairs Associate from January 2015 to March 2021, where responsibilities involved managing submissions of biological and pharmaceutical products, and at Abbott, where Nahla was a Regulatory Affairs Associate involved in a significant separation project. Earlier in a regulatory site officer role at Kahira, Nahla handled regulatory activities for Abbott's licensed products. Nahla holds a Master's degree in Pharmaceutical Microbiology and Biotechnology and a Bachelor's degree in Veterinary Sciences from the University of Veterinary and Pharmaceutical Sciences Brno.
This person is not in any teams
This person is not in any offices
Acino
2 followers
Acino is a Swiss pharmaceutical company headquartered in Zurich, with a clear focus on high-growth markets. We deliver quality pharmaceuticals to promote affordable healthcare and leverage our high-quality pharmaceutical manufacturing capabilities and network to supply leading companies through contract manufacturing and out-licensing. For more information: www.acino.swiss *** By engaging with Acino on LinkedIn (or any other Acino social media channel), you are agreeing to our Social Media Community Guidelines. If you do not agree to them, do not engage with Acino on social media. Please read our detailed community guidelines carefully here: https://acino.swiss/acino_social_media_community_guidelines_may2022 ***